Role of endoplasmic reticulum stress in acrolein-induced endothelial activation

Toxicology and Applied Pharmacology

Volumn 234, Issue 1, 2009, Pages 14-24

  Haberzettl, Petra ^a   Vladykovskaya, Elena ^a   Srivastava, Sanjay ^a   Bhatnagar, Aruni ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Aldehydes; Endothelial dysfunction; Human; Oxidative stress; Pollution

Indexed keywords

ACROLEIN; ACTIVATING TRANSCRIPTION FACTOR 3; ACTIVATING TRANSCRIPTION FACTOR 4; ALDEHYDE; ARYLBUTYRIC ACID DERIVATIVE; CHAPERONE; CYTOKINE; GLUCOSE REGULATED PROTEIN 78; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INITIATION FACTOR 2ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; X BOX BINDING PROTEIN 1;

ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; OXIDATIVE STRESS; POLLUTION; POLYMERASE CHAIN REACTION; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ACROLEIN; CYTOKINES; DNA-BINDING PROTEINS; ENDOPLASMIC RETICULUM; ENDOTHELIAL CELLS; ENVIRONMENTAL POLLUTANTS; EUKARYOTIC INITIATION FACTOR-2; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR CHAPERONES; NF-KAPPA B; OXIDATIVE STRESS; PHOSPHORYLATION; RNA SPLICING; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION FACTORS; UMBILICAL VEINS;

EID: 57149117113     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.09.019     Document Type: Article

References (51)

1. Adams Jr. J.D., and Klaidman L.K. Acrolein-induced oxygen radical formation. Free Radic. Biol. Med. 15 (1993) 187-193
2. Alary J., Debrauwer L., Fernandez Y., Cravedi J.P., Rao D., and Bories G. 1,4-Dihydroxynonene mercapturic acid, the major end metabolite of exogenous 4-hydroxy-2-nonenal, is a physiological component of rat and human urine. Chem. Res. Toxicol. 11 (1998) 130-135
3. Anderson M.M., Hazen S.L., Hsu F.F., and Heinecke J.W. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of inflammation. J. Clin. Invest. 99 (1997) 424-432
4. Averous J., Bruhat A., Jousse C., Carraro V., Thiel G., and Fafournoux P. Induction of CHOP expression by amino acid limitation requires both ATF4 expression and ATF2 phosphorylation. J. Biol. Chem. 279 (2004) 5288-5297
5. Awe S.O., Adeagbo A.S., D'Souza S.E., Bhatnagar A., and Conklin D.J. Acrolein induces vasodilatation of rodent mesenteric bed via an EDHF-dependent mechanism. Toxicol. Appl. Pharmacol. 217 (2006) 266-276
6. Barnoya J., and Glantz S.A. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation 111 (2005) 2684-2698
7. Bhatnagar A. Electrophysiological effects of 4-hydroxynonenal, an aldehydic product of lipid peroxidation, on isolated rat ventricular myocytes. Circ. Res. 76 (1995) 293-304
8. Bhatnagar A. Cardiovascular pathophysiology of environmental pollutants. Am. J. Physiol. Heart Circ.Physiol. 286 (2004) H479-H485
9. Bhatnagar A. Environmental cardiology: studying mechanistic links between pollution and heart disease. Circ. Res. 99 (2006) 692-705
10. Biswal S., cquaah-Mensah G., Datta K., Wu X., and Kehrer J.P. Inhibition of cell proliferation and AP-1 activity by acrolein in human A549 lung adenocarcinoma cells due to thiol imbalance and covalent modifications. Chem. Res. Toxicol. 15 (2002) 180-186
11. Burcham P.C., and Pyke S.M. Hydralazine inhibits rapid acrolein-induced protein oligomerization: role of aldehyde scavenging and adduct trapping in cross-link blocking and cytoprotection. Mol. Pharmacol. 69 (2006) 1056-1065
12. Burrows J.A., Willis L.K., and Perlmutter D.H. Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: a potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc. Natl. Acad. Sci. U.S.A 97 (2000) 1796-1801
13. Carmella S.G., Chen M., Zhang Y., Zhang S., Hatsukami D.K., and Hecht S.S. Quantitation of acrolein-derived (3-hydroxypropyl)mercapturic acid in human urine by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: effects of cigarette smoking. Chem. Res. Toxicol. 20 (2007) 986-990
14. Daimon M., Sugiyama K., Kameda W., Saitoh T., Oizumi T., Hirata A., Yamaguchi H., Ohnuma H., Igarashi M., and Kato T. Increased urinary levels of pentosidine, pyrraline and acrolein adduct in type 2 diabetes. Endocr. J. 50 (2003) 61-67
15. Daugherty A., Webb N.R., Rateri D.L., and King V.L. Thematic review series: the immune system and atherogenesis. Cytokine regulation of macrophage functions in atherogenesis. J. Lipid Res. 46 (2005) 1812-1822
16. Esterbauer H., Schaur R.J., and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11 (1991) 81-128
17. Feron V.J., Til H.P., de V.F., Woutersen R.A., Cassee F.R., and van Bladeren P.J. Aldehydes: occurrence, carcinogenic potential, mechanism of action and risk assessment. Mutat. Res. 259 (1991) 363-385
18. Ghilarducci D.P., and Tjeerdema R.S. Fate and effects of acrolein. Rev. Environ. Contam. Toxicol. 144 (1995) 95-146
19. Hill B.G., Haberzettl P., Ahmed Y., Srivastava S., and Bhatnagar A. Unsaturated lipid peroxidation-derived aldehydes activate autophagy in vascular smooth-muscle cells. Biochem. J. 410 (2008) 525-534
20. Horton N.D., Biswal S.S., Corrigan L.L., Bratta J., and Kehrer J.P. Acrolein causes inhibitor kappaB-independent decreases in nuclear factor kappaB activation in human lung adenocarcinoma (A549) cells. J. Biol. Chem. 274 (1999) 9200-9206
21. Howard G., Wagenknecht L.E., Burke G.L., ez-Roux A., Evans G.W., McGovern P., Nieto F.J., and Tell G.S. Cigarette smoking and progression of atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. JAMA 279 (1998) 119-124
22. Hyvelin J.M., Roux E., Prevost M.C., Savineau J.P., and Marthan R. Cellular mechanisms of acrolein-induced alteration in calcium signaling in airway smooth muscle. Toxicol. Appl. Pharmacol. 164 (2000) 176-183
23. Jaimes E.A., DeMaster E.G., Tian R.X., and Raij L. Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1031-1036
24. Kokame K., Kato H., and Miyata T. Identification of ERSE-II, a new cis-acting element responsible for the ATF6-dependent mammalian unfolded protein response. J. Biol. Chem. 276 (2001) 9199-9205
25. Lambert C., Li J., Jonscher K., Yang T.C., Reigan P., Quintana M., Harvey J., and Freed B.M. Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-kappaB1 DNA binding domain. J. Biol. Chem. 282 (2007) 19666-19675
26. Li L., Jiang L., Geng C., Cao J., and Zhong L. The role of oxidative stress in acrolein-induced DNA damage in HepG2 cells. Free Radic. Res. 42 (2008) 354-361
27. Lovell M.A., Xie C., and Markesbery W.R. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol. Aging 22 (2001) 187-194
28. Luo J., Hill B.G., Gu Y., Cai J., Srivastava S., Bhatnagar A., and Prabhu S.D. Mechanisms of acrolein-induced myocardial dysfunction: implications for environmental and endogenous aldehyde exposure. Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H3673-H3684
29. Ma Y., and Hendershot L.M. Herp is dually regulated by both the endoplasmic reticulum stress-specific branch of the unfolded protein response and a branch that is shared with other cellular stress pathways. J. Biol. Chem. 279 (2004) 13792-13799
30. Misonou Y., Asahi M., Yokoe S., Miyoshi E., and Taniguchi N. Acrolein produces nitric oxide through the elevation of intracellular calcium levels to induce apoptosis in human umbilical vein endothelial cells: implications for smoke angiopathy. Nitric Oxide. 14 (2006) 180-187
31. Mottram D.S., Wedzicha B.L., and Dodson A.T. Acrylamide is formed in the Maillard reaction. Nature 419 (2002) 448-449
32. Orosz Z., Csiszar A., Labinskyy N., Smith K., Kaminski P.M., Ferdinandy P., Wolin M.S., Rivera A., and Ungvari Z. Cigarette smoke-induced proinflammatory alterations in the endothelial phenotype: role of NAD(P)H oxidase activation. Am. J. Physiol. Heart Circ. Physiol 292 (2007) H130-H139
33. Ozcan U., Yilmaz E., Ozcan L., Furuhashi M., Vaillancourt E., Smith R.O., Gorgun C.Z., and Hotamisligil G.S. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313 (2006) 1137-1140
34. Parent R.A., Caravello H.E., and Sharp D.E. Metabolism and distribution of [2,3-14C]acrolein in Sprague-Dawley rats. J. Appl. Toxicol. 16 (1996) 449-457
35. Park Y.S., Kim J., Misonou Y., Takamiya R., Takahashi M., Freeman M.R., and Taniguchi N. Acrolein induces cyclooxygenase-2 and prostaglandin production in human umbilical vein endothelial cells: roles of p38 MAP kinase. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 1319-1325
36. Patel J.M., and Block E.R. Acrolein-induced injury to cultured pulmonary artery endothelial cells. Toxicol. Appl. Pharmacol. 122 (1993) 46-53
37. Peters A., von K.S., Heier M., Trentinaglia I., Hormann A., Wichmann H.E., and Lowel H. Exposure to traffic and the onset of myocardial infarction. N. Engl. J. Med. 351 (2004) 1721-1730
38. Roethig H.J., Zedler B.K., Kinser R.D., Feng S., Nelson B.L., and Liang Q. Short-term clinical exposure evaluation of a second-generation electrically heated cigarette smoking system. J. Clin. Pharmacol. 47 (2007) 518-530
39. Rubenstein R.C., Egan M.E., and Zeitlin P.L. In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR. J. Clin. Invest 100 (1997) 2457-2465
40. Schroder M., and Kaufman R.J. The mammalian unfolded protein response. Annu. Rev. Biochem. 74 (2005) 739-789
41. Schulze A., Standera S., Buerger E., Kikkert M., van V.S., Wiertz E., Koning F., Kloetzel P.M., and Seeger M. The ubiquitin-domain protein HERP forms a complex with components of the endoplasmic reticulum associated degradation pathway. J. Mol. Biol. 354 (2005) 1021-1027
42. Shao B., Fu X., McDonald T.O., Green P.S., Uchida K., O'Brien K.D., Oram J.F., and Heinecke J.W. Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I. J. Biol. Chem. 280 (2005) 36386-36396
43. Tamarappoo B.K., and Verkman A.S. Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones. J. Clin. Invest. 101 (1998) 2257-2267
44. Tanel A., and verill-Bates D.A. The aldehyde acrolein induces apoptosis via activation of the mitochondrial pathway. Biochim. Biophys. Acta. 1743 (2005) 255-267
45. Tedgui A., and Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 86 (2006) 515-581
46. Tsakadze N.L., Srivastava S., Awe S.O., Adeagbo A.S., Bhatnagar A., and D'Souza S.E. Acrolein-induced vasomotor responses of rat aorta. Am. J. Physiol Heart Circ. Physiol. 285 (2003) H727-H734
47. Uchida K., Kanematsu M., Morimitsu Y., Osawa T., Noguchi N., and Niki E. Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J. Biol. Chem. 273 (1998) 16058-16066
48. Uchida K., Kanematsu M., Sakai K., Matsuda T., Hattori N., Mizuno Y., Suzuki D., Miyata T., Noguchi N., Niki E., and Osawa T. Protein-bound acrolein: potential markers for oxidative stress. Proc. Natl. Acad. Sci. U.S.A 95 (1998) 4882-4887
49. Wu C.C., Hsieh C.W., Lai P.H., Lin J.B., Liu Y.C., and Wung B.S. Upregulation of endothelial heme oxygenase-1 expression through the activation of the JNK pathway by sublethal concentrations of acrolein. Toxicol. Appl. Pharmacol. 214 (2006) 244-252
50. Xu C., Bailly-Maitre B., and Reed J.C. Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Invest. 115 (2005) 2656-2664
51. Zhang K., and Kaufman R.J. Signaling the unfolded protein response from the endoplasmic reticulum. J. Biol. Chem. 279 (2004) 25935-25938